The ACI have received clarification from the FSA on several points concerning novel foods dossier applications that have been raised by our members.
With the new novel foods regulation deadline looming this event will provide a unique opportunity to listen and engage with representatives of the UK’s regulator the Foods Standards Agency as well as industry experts from trading standards, toxicology, and the analytical testing and legal worlds.
The purpose of this timeline is to highlight the importance that CBD companies must start the process of Novel Foods applications now in order to avoid disruption in their distribution channels when FSA regulations come into force. We include the data required in a Novel Foods dossier followed by an estimate of time to produce this data.
The Food Standards Agency (FSA) confirmed last week, in a virtual meeting with The ACI, that they intend to stick to their deadline of 31 March 2021 for CBD companies to have a validated Novel Foods application. According to the FSA. “After this date, only products for which the FSA has a valid application will be allowed to remain on the market.”
After speculation the FSA would extend the deadline for all UK businesses, The ACI arranged a meeting to clarify several points to enable us to guide our members, and the industry at large.
The FSA made clear that
The Food Standards Agency (FSA) is giving the CBD industry a deadline of 31 March 2021 to submit valid novel food authorisation applications. After 31 March next year, only products which have submitted a valid application will be allowed to remain on the market. The authorisation process ensures novel foods meet legal standards, including on safety and content.